Zobrazeno 1 - 10
of 935
pro vyhledávání: '"G. MICHAEL FELKER"'
Autor:
Satoshi Shoji, Lisa Kaltenbach, Bradi B. Granger, Gregg C. Fonarow, Hussein R. Al‐Khalidi, Nancy M. Albert, Javed Butler, Larry A. Allen, David E. Lanfear, Jennifer T. Thibodeau, Brittany M. Chapman, Sandra M. Oliver‐McNeil, G. Michael Felker, Ileana L. Pina, Christopher B. Granger, Adrian F. Hernandez, Adam D. DeVore
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 24 (2024)
Background Significant gap remains in the implementation of guideline‐directed medical therapy (GDMT) in patients with heart failure after a hospitalization. We aimed to evaluate the use and titration of GDMT at discharge and over a 12‐month peri
Externí odkaz:
https://doaj.org/article/f4e18187e5ff4ae888c3f5c2e8648212
Autor:
Reza Mohebi, Yuxi Liu, Javed Butler, G. Michael Felker, Jonathan H. Ward, Margaret F. Prescott, Ileana L. Piña, Scott D. Solomon, James L. Januzzi Jr
Publikováno v:
ESC Heart Failure, Vol 10, Iss 5, Pp 3133-3140 (2023)
Abstract Aims Serial assessment of natriuretic peptides is widely utilized in heart failure clinics. Uncertainty exists regarding the value of multiple natriuretic peptide measurements and how they might be best interpreted. Methods and results Six h
Externí odkaz:
https://doaj.org/article/70f8c15ae4a44f15b7ce8094b58c2323
Autor:
Josephine Harrington, Jie‐Lena Sun, Gregg C. Fonarow, Stephen B. Heitner, Punag H. Divanji, Gary Binder, Larry A. Allen, Brooke Alhanti, Clyde W. Yancy, Nancy M. Albert, Adam D. DeVore, G. Michael Felker, Stephen J. Greene
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 10 (2023)
Background Many patients with heart failure (HF) have severely reduced ejection fraction but do not meet threshold for consideration of advanced therapies (ie, stage D HF). The clinical profile and health care costs associated with these patients in
Externí odkaz:
https://doaj.org/article/1562516935a04e21a697a6a639dfaab1
Autor:
Reza Mohebi, Yuxi Liu, G. Michael Felker, Jonathan H. Ward, Ileana L. Piña, Javed Butler, Scott D. Solomon, James L. Januzzi
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 8 (2023)
Externí odkaz:
https://doaj.org/article/2103b4a1a3f24376903d6de4ae23f310
Autor:
Joseph B. Lerman, Stephanie N. Giamberardino, Adrian F. Hernandez, G. Michael Felker, Svati H. Shah, Robert W. McGarrah
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Heart failure with reduced ejection fraction (HFrEF) is increasingly treated with medications for type 2 diabetes mellitus (T2DM). Whether metabolic derangements in HFrEF and T2DM are associated with differential outcomes remains unclear. Th
Externí odkaz:
https://doaj.org/article/295fb7db955a4b4fac37fd8e0e460f53
Autor:
Justin A. Ezekowitz, Wendimagegn Alemayehu, Sarah Rathwell, Andrew D. Grant, Mona Fiuzat, David J. Whellan, Tariq Ahmad, Kirkwood Adams, Ileana L. Piña, Lawton S. Cooper, James L. Januzzi, Eric S. Leifer, Daniel Mark, Christopher M. O'Connor, G. Michael Felker
Publikováno v:
ESC Heart Failure, Vol 9, Iss 1, Pp 77-86 (2022)
Abstract Aims N‐terminal pro‐b‐type natriuretic peptide (NT‐proBNP) values may be influenced by patient factors beyond the severity of illness, including atrial fibrillation (AF), renal dysfunction, or increased body mass index (BMI). We hypo
Externí odkaz:
https://doaj.org/article/d9ba27970e694527b9600c5e88424965
Autor:
Abhinav Sharma, Stephen Greene, Muthiah Vaduganathan, Marat Fudim, Andrew P. Ambrosy, Jie‐Lena Sun, Steven E. McNulty, Adrian F. Hernandez, Barry A. Borlaug, Eric J. Velazquez, Robert J. Mentz, Adam D. DeVore, Brooke Alhanti, Kenneth Margulies, G. Michael Felker
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 2608-2616 (2021)
Abstract Aims Associations between growth differentiation factor‐15 (GDF‐15), cardiovascular outcomes, and exercise capacity among patients with a recent hospitalization for heart failure (HHF) and heart failure with reduced ejection fraction (HF
Externí odkaz:
https://doaj.org/article/385af4f80c514fc69c535399a22fde82
Autor:
Lauren K. Truby, Jessica A. Regan, Stephanie N. Giamberardino, Olga Ilkayeva, James Bain, Christopher B. Newgard, Christopher M. O’Connor, G. Michael Felker, William E. Kraus, Robert W. McGarrah, Svati H. Shah
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-10 (2021)
Abstract Background Whether differences in circulating long chain acylcarnitines (LCAC) are seen in heart failure (HF) patients with and without diabetes mellitus (DM), and whether these biomarkers report on exercise capacity and clinical outcomes, r
Externí odkaz:
https://doaj.org/article/8e4ae4722022434d889491348a64d28b
Autor:
Fouad Chouairi, BS, Justin Pacor, MD, P. Elliott Miller, MD, Michael A. Fuery, MD, Cesar Caraballo, MD, Sounok Sen, MD, Eric S. Leifer, PhD, G. Michael Felker, MD, MHS, Mona Fiuzat, PharmD, Christopher M. O’Connor, MD, James L. Januzzi, MD, Daniel J. Friedman, MD, Nihar R. Desai, MD, MPH, Tariq Ahmad, MD, MPH, James V. Freeman, MD, MPH, MS
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 2, Pp 447-455 (2021)
Objective: To evaluate effects of atrial fibrillation (AF) on cardiac biomarkers and outcomes in a trial population of patients with heart failure (HF) with reduced ejection fraction treated with optimal guideline-directed medical therapy. Methods: W
Externí odkaz:
https://doaj.org/article/48f75c6827664f9e8ed830056cd2819b
Autor:
Amir Razaghizad, Emily Oulousian, Varinder Kaur Randhawa, João Pedro Ferreira, James M. Brophy, Stephen J. Greene, Julian Guida, G. Michael Felker, Marat Fudim, Michael Tsoukas, Tricia M. Peters, Thomas A. Mavrakanas, Nadia Giannetti, Justin Ezekowitz, Abhinav Sharma
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 10 (2022)
Background Clinical prediction models have been developed for hospitalization for heart failure in type 2 diabetes. However, a systematic evaluation of these models’ performance, applicability, and clinical impact is absent. Methods and Results We
Externí odkaz:
https://doaj.org/article/7f05e3fbff4e4caf944a6d75a396c00b